ici 118 551 (MedChemExpress)
Structured Review
![(A and B) Distinct expression of Adrb2 in neutrophils. (A) The average expression of adrenergic receptors was projected onto the UMAP plot of neutrophil subtypes defined in . (B) Immunosuppressive neutrophils were FACS-sorted from the metastatic lung tumors of MMTV-PyMT +/- mice 9 weeks after the onset of primary breast cancer. Expression levels of adrenergic receptors were determined by the qPCR analyses. n = 4. (C) The sympathetic neurotransmitter norepinephrine directly promotes the function of immunosuppressive neutrophils. Immunosuppressive neutrophils were FACS-sorted from the metastatic lung tumors of MMTV-PyMT +/- mice and then in vitro treated with norepinephrine (NE). mRNA levels of Cd274 and Il18 were examined by the qPCR analyses. n = 3, mean ± SEM, * p < 0.05 (Student’s t -test). (D to G) Ablation of sympathetic signals abolishes immunosuppressive neutrophils in lung tumors. (D and E) The wild-type mice were intranasally treated with 6-OHDA or control vehicle [PBS containing 0.01% vitamin C (Vc)] and then inoculated with LLC cancer cells. (D) Representative images of the lung tumors processed by conventional tissue sectioning and CD274/Ly6G co-immunostaining were shown. (E) Numbers of immunosuppressive neutrophils in the lung tumors of Vc-treated or 6-OHDA-treated mice were quantified. n = 10, mean ± SEM, * p < 0.05 (Student’s t -test). (F and G) MMTV-PyMT +/- female mice at 1 week after the onset of primary breast cancer were intranasally treated with 6-OHDA or control vehicle. (F) Representative images of the metastatic lung tumors processed by conventional tissue sectioning and CD274/Ly6G co-immunostaining were shown. (G) Numbers of immunosuppressive neutrophils in the metastatic lung tumors of Vc-treated or 6-OHDA-treated MMTV-PyMT +/- mice were quantified. n = 10, mean ± SEM, * p < 0.05 (Student’s t -test). (H and I) Blockage of the Adrb2 signal potentiates the anti-PD-L1 immunotherapy. MMTV-PyMT +/- female mice at 7 weeks after the onset of primary breast cancer were intravenously injected with the anti-PD-L1 antibody once per week without or with the daily treatment of the Adrb2 antagonist <t>ICI-118,551.</t> The intact lung tissues (left lobes) of the mice at 9 weeks after the onset of primary breast cancer were processed through the whole-tissue PyMT-immunolabeling. (H) Representative 3D-projection images at 1.26× magnification of the lightsheet imaging were shown. (I) Numbers and sizes of the metastatic lung tumors of MMTV-PyMT +/- mice under indicated conditions were counted. 10 mice per condition, * p < 0.05 (two-way ANOVA test).](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_34/10__1101_slash_2024__02__15__580434/10__1101_slash_2024__02__15__580434___F4.large.jpg)
Ici 118 551, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ici 118 551/product/MedChemExpress
Average 93 stars, based on 11 article reviews
Images
1) Product Images from "Sympathetic Signals Promote Immunosuppressive Neutrophils in Lung Tumors"
Article Title: Sympathetic Signals Promote Immunosuppressive Neutrophils in Lung Tumors
Journal: bioRxiv
doi: 10.1101/2024.02.15.580434
Figure Legend Snippet: (A and B) Distinct expression of Adrb2 in neutrophils. (A) The average expression of adrenergic receptors was projected onto the UMAP plot of neutrophil subtypes defined in . (B) Immunosuppressive neutrophils were FACS-sorted from the metastatic lung tumors of MMTV-PyMT +/- mice 9 weeks after the onset of primary breast cancer. Expression levels of adrenergic receptors were determined by the qPCR analyses. n = 4. (C) The sympathetic neurotransmitter norepinephrine directly promotes the function of immunosuppressive neutrophils. Immunosuppressive neutrophils were FACS-sorted from the metastatic lung tumors of MMTV-PyMT +/- mice and then in vitro treated with norepinephrine (NE). mRNA levels of Cd274 and Il18 were examined by the qPCR analyses. n = 3, mean ± SEM, * p < 0.05 (Student’s t -test). (D to G) Ablation of sympathetic signals abolishes immunosuppressive neutrophils in lung tumors. (D and E) The wild-type mice were intranasally treated with 6-OHDA or control vehicle [PBS containing 0.01% vitamin C (Vc)] and then inoculated with LLC cancer cells. (D) Representative images of the lung tumors processed by conventional tissue sectioning and CD274/Ly6G co-immunostaining were shown. (E) Numbers of immunosuppressive neutrophils in the lung tumors of Vc-treated or 6-OHDA-treated mice were quantified. n = 10, mean ± SEM, * p < 0.05 (Student’s t -test). (F and G) MMTV-PyMT +/- female mice at 1 week after the onset of primary breast cancer were intranasally treated with 6-OHDA or control vehicle. (F) Representative images of the metastatic lung tumors processed by conventional tissue sectioning and CD274/Ly6G co-immunostaining were shown. (G) Numbers of immunosuppressive neutrophils in the metastatic lung tumors of Vc-treated or 6-OHDA-treated MMTV-PyMT +/- mice were quantified. n = 10, mean ± SEM, * p < 0.05 (Student’s t -test). (H and I) Blockage of the Adrb2 signal potentiates the anti-PD-L1 immunotherapy. MMTV-PyMT +/- female mice at 7 weeks after the onset of primary breast cancer were intravenously injected with the anti-PD-L1 antibody once per week without or with the daily treatment of the Adrb2 antagonist ICI-118,551. The intact lung tissues (left lobes) of the mice at 9 weeks after the onset of primary breast cancer were processed through the whole-tissue PyMT-immunolabeling. (H) Representative 3D-projection images at 1.26× magnification of the lightsheet imaging were shown. (I) Numbers and sizes of the metastatic lung tumors of MMTV-PyMT +/- mice under indicated conditions were counted. 10 mice per condition, * p < 0.05 (two-way ANOVA test).
Techniques Used: Expressing, In Vitro, Control, Immunostaining, Injection, Immunolabeling, Imaging